AKBA — Price & Float Short

—— Fair value ★ EPS beat ★ EPS miss —— Target Price

Float Short %

7.27

Margin Of Safety %

Put/Call OI Ratio

0.17

EPS Next Q Diff

EPS Last/This Y

-0.08

EPS This/Next Y

-0.09

Price

0.91

Target Price

3.8

Analyst Recom

1.4

Performance Q

-22.89

Upside

-257.1%

Beta

0.19

Ticker: AKBA

19 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-07-13	AKBA	1.39	0.19	1.16	37785
2026-07-14	AKBA	1.41	0.19	0.02	37835
2026-07-15	AKBA	1.385	0.19	0.00	37848
2026-07-16	AKBA	1.41	0.19	1.18	38004
2026-07-17	AKBA	1.345	0.19	0.53	38030
2026-07-20	AKBA	1.285	0.15	4.19	29712
2026-07-21	AKBA	1.31	0.18	0.00	30425
2026-07-22	AKBA	1.265	0.18	0.27	30447
2026-07-23	AKBA	1.23	0.18	0.01	30852
2026-07-24	AKBA	1.225	0.18	0.03	30813
2026-07-27	AKBA	1.285	0.18	0.00	31071
2026-07-28	AKBA	1.28	0.18	0.00	31017
2026-07-29	AKBA	1.27	0.18	0.00	31053
2026-07-30	AKBA	1.36	0.18	0.03	31056
2026-07-31	AKBA	1.33	0.18	0.00	31105
2026-08-03	AKBA	1.31	0.18	0.00	31113
2026-08-04	AKBA	1.315	0.18	0.00	31164
2026-08-05	AKBA	1.28	0.18	0.01	31388
2026-08-07	AKBA	0.9068	0.17	0.02	32514
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

19 items 1 of 1

20 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-07-13	AKBA	1.39	-100.0	-	-0.10
2026-07-14	AKBA	1.41	-100.0	-	-0.10
2026-07-15	AKBA	1.38	-100.0	-	-0.10
2026-07-16	AKBA	1.41	-100.0	-	-0.10
2026-07-17	AKBA	1.34	-100.0	-	-0.10
2026-07-20	AKBA	1.29	-100.0	-	-0.10
2026-07-21	AKBA	1.31	-100.0	-	-0.10
2026-07-22	AKBA	1.27	-100.0	-	-0.10
2026-07-23	AKBA	1.23	-100.0	-	-0.10
2026-07-24	AKBA	1.23	-100.0	-	-0.10
2026-07-27	AKBA	1.29	-100.0	-	-0.10
2026-07-28	AKBA	1.28	-100.0	-	-0.10
2026-07-29	AKBA	1.27	-100.0	-	-0.10
2026-07-30	AKBA	1.36	-100.0	-	-0.10
2026-07-31	AKBA	1.33	-100.0	-	-0.10
2026-08-03	AKBA	1.31	-100.0	-	-0.10
2026-08-04	AKBA	1.31	-100.0	-	-0.10
2026-08-05	AKBA	1.28	-100.0	-	-0.10
2026-08-06	AKBA	0.95	-100.0	-	-0.10
2026-08-07	AKBA	0.91	0.0	-	-0.10
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

20 items 1 of 1

20 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-07-13	AKBA	-7.79	-6.74	7.35
2026-07-14	AKBA	-7.79	-6.74	7.35
2026-07-15	AKBA	-7.79	-6.74	7.35
2026-07-16	AKBA	-7.79	-6.74	7.35
2026-07-17	AKBA	-7.79	-6.74	7.35
2026-07-20	AKBA	-7.79	-6.75	7.35
2026-07-21	AKBA	-7.79	-6.75	7.35
2026-07-22	AKBA	-7.79	-6.75	7.35
2026-07-23	AKBA	-7.79	-6.75	7.35
2026-07-24	AKBA	-7.79	-6.75	7.35
2026-07-27	AKBA	-7.79	-6.74	7.32
2026-07-28	AKBA	-7.79	-6.74	7.32
2026-07-29	AKBA	-7.79	-6.74	7.32
2026-07-30	AKBA	-7.79	-6.74	7.32
2026-07-31	AKBA	-7.79	-6.74	7.32
2026-08-03	AKBA	-7.79	-6.27	7.32
2026-08-04	AKBA	-7.79	-6.27	7.27
2026-08-05	AKBA	0.23	-6.27	7.27
2026-08-06	AKBA	0.23	-6.27	7.27
2026-08-07	AKBA	0.23	-6.27	7.27
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

20 items 1 of 1

Last Quarter Act. EPS

-0.02

Avg. EPS Est. Current Quarter

-0.03

Avg. EPS Est. Next Quarter

-0.02

Insider Transactions

0.23

Institutional Transactions

-6.27

Beta

0.19

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

0.95

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

77.7

Max Drawdown 5-Year %

-92.5

Target Price

3.8

P/E

Forward P/E

PEG

P/S

1.15

P/B

9.88

P/Free Cash Flow

6.26

EPS

-0.11

Average EPS Est. Cur. Y

-0.1

EPS Next Y. (Est.)

-0.19

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-13.54

Relative Volume

2.1

Return on Equity vs Sector %

-100

Return on Equity vs Industry %

-100

EPS 1 7Days Diff

-0.1

EPS 1 30Days Diff

-0.12

EBIT Estimation

◆ AKBA Healthcare

$0.91

📉

Swing / Pullback

Buy the dip on strong trends

N/A

WEAK

Trend

16/20

Pullback

11/25

Volume

3/15

Valuation

15/20

TP/AR

2/10

Options

7/10

RSI

27.4

Range 1M

8.9%

Sup Dist

4.8%

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

15/25

Growth

7/30

Estimates

1/20

Inst/Vol

3/15

Options

10/10

EPS Yr

-620%

EPS NY

-88.9%

52W%

3.1%

💎

Long-Term Value

Quality companies, undervalued

N/A

WEAK

🟢 BUY +129.7% upside

Quality

6/30

Valuation

18/30

Growth

3/25

Stability

1/10

LT Trend

4/5

Upside

+129.7%

Quality

MoS

AKBA — P/E HistoricalBiotechnology

Akebia Therapeutics, Inc.

Sector: Healthcare

Industry: Drug Manufacturers - Specialty & Generic

Employees: 194

Akebia Therapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics for patients with kidney diseases. Its product portfolio includes Vafseo (vadadustat), an oral hypoxia-inducible factor prolyl hydroxylase, for the treatment of anemia due to chronic kidney disease (CKD) in dialysis-dependent (DD) and non-dialysis dependent (NDD) patients; and Auryxia, a ferric citrate that is used to control the serum phosphorus levels in adult patients with DD-CKD and the treatment of iron deficiency anemia in adult patients with NDD-CKD. The company is also developing AKB-9090, which is in Phase 2 clinical trial for treating cardiac surgery-related acute kidney injury and acute respiratory distress syndrome; and AKB-10108 for the treatment of retinopathy of prematurity in neonates. The company has license and collaboration agreements with Tanabe Pharma Corporation for the development and commercialization of Vafseo in Japan and other Asian countries; Vafseo License and Collaboration Agreements; CSL Vifor Agreements; Averoa License Agreement; License Agreement with Panion & BF Biotech, Inc.; Cyclerion Therapeutics License Agreement; and Q32 Asset Purchase Agreement. Akebia Therapeutics, Inc. was incorporated in 2007 and is headquartered in Cambridge, Massachusetts.

AKBA

Latest News

—

Caricamento notizie per AKBA…

stock quote shares AKBA – Akebia Therapeutics Inc. Stock Price stock today

news today AKBA – Akebia Therapeutics Inc. stock forecast ,stock prediction 2023 2024 2025

marketwatch AKBA – Akebia Therapeutics Inc. yahoo finance google finance

stock history AKBA – Akebia Therapeutics Inc. invest stock market

stock prices AKBA premarket after hours

ticker AKBA fair value insiders trading

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Upside

Beta

Ticker: AKBA

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Latest News

Last Quarter Act. EPS

Average EPS Est. Cur. Y